| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.12.25 | Property or shares? The No.1 investment of the past 25 years | ||
| 12.12.25 | Top 10 at 11: ASX sings on powerful gains in gold and silver overnight | ||
| 11.12.25 | Rise and Shine: Everything you need to know before the ASX opens | ||
| 11.12.25 | Unicorns Podcast: Compare Club's mission to help Australians switch and save | ||
| 11.12.25 | Long Shortz with Racura: Inside the $3.22M raise powering a lung cancer trial | ||
| 11.12.25 | Hawkish cut, dovish reality? The Fed's 2026 path is taking shape | ||
| 11.12.25 | IPO Watch: Gas explorer Macallum New Energy chases $6m IPO with prime Perth Basin acreage | ||
| 11.12.25 | Resources Top 5: Marmota rockets as Greenewood drilling uncovers eye-catching gold grades | ||
| 11.12.25 | Closing Bell: Confusion reigns after split Fed decision, but resources tick ASX higher | ||
| 11.12.25 | Self-managed superannuation slowly becomes a family affair | ||
| 11.12.25 | Papua New Guinea eyes mining revival as key developments line up | ||
| 11.12.25 | Lunch Wrap: ASX powers through the Fed fog; Marmota lights up with bonanza assays | ||
| 11.12.25 | Health Check: Argenica sharpens stroke trial strategy after AI review | ||
| 11.12.25 | Merry Christmas Neurizon as FDA clears NUZ-001 for HEALEY ALS Platform Trial | ||
| 10.12.25 | IPO Watch: Dormant assets come to market as Exultant raises $5m | ||
| 10.12.25 | Explorers Podcast: Barkly's move to unlock NT's rare earths potential | ||
| 10.12.25 | Long Shortz with Australian Oil Company: Powering up the Sunshine State | ||
| 10.12.25 | Mining IPOs roar back to life as 2025 marks the dawn of a new boom | ||
| 10.12.25 | Turning waste into wealth: Parkway eyes billion-dollar brine solution | ||
| 10.12.25 | Closing Bell: Precious metals bring the sparkle as market closes flat | ||
| 10.12.25 | Resources Top 5: Platina almost doubles footprint in prolific Laverton gold district | ||
| 10.12.25 | A $173bn wealth transfer boom expected for Australia | ||
| 10.12.25 | Health Check: Cogstate suffers a nasty share price head knock, but its future 'has never looked brighter' | ||
| 10.12.25 | Lunch Wrap: ASX cautious before Fed verdict, gold stocks lead the pack | ||
| 10.12.25 | Break it Down: Astral banks $65M to fast-track Mandilla gold development |